The Disease Interception Accelerator established a partnership with UbiVac, a privately held, clinical-stage, immuno-oncology company for the development of an immunotherapy that is intended to intercept oral cavity/oropharyngeal cancer.
Partnership to Intercept Oral Cavity/Oropharyngeal Cancer
World Without Disease Accelerator
World Without Disease Accelerator
Oncology
Oncology
Human lung bronchioalveolar carcinoma cell
Disease Interception Accelerator
Disease Interception Accelerator
Partnerships
Partnerships
Wendy Olsen, lincs